<?xml version="1.0" encoding="UTF-8"?>
<ref id="ddr21709-bib-0163">
 <mixed-citation publication-type="journal" id="ddr21709-cit-0163">
  <string-name>
   <surname>Tai</surname>, 
   <given-names>W.</given-names>
  </string-name>, 
  <string-name>
   <surname>He</surname>, 
   <given-names>L.</given-names>
  </string-name>, 
  <string-name>
   <surname>Zhang</surname>, 
   <given-names>X.</given-names>
  </string-name>, 
  <string-name>
   <surname>Pu</surname>, 
   <given-names>J.</given-names>
  </string-name>, 
  <string-name>
   <surname>Voronin</surname>, 
   <given-names>D.</given-names>
  </string-name>, 
  <string-name>
   <surname>Jiang</surname>, 
   <given-names>S.</given-names>
  </string-name>, &amp; 
  <string-name>
   <surname>Du</surname>, 
   <given-names>L.</given-names>
  </string-name> (
  <year>2020</year>). 
  <article-title>Characterization of the receptor‐binding domain (RBD) of 2019 novel coronavirus: Implication for development of RBD protein as a viral attachment inhibitor and vaccine</article-title>. 
  <source xml:lang="en">Cellular &amp; Molecular Immunology</source>, 
  <volume>17</volume>, 
  <fpage>613</fpage>–
  <lpage>620</lpage>. 
  <pub-id pub-id-type="doi">10.1038/s41423-020-0400-4</pub-id>
  <pub-id pub-id-type="pmid">32203189</pub-id>
 </mixed-citation>
</ref>
